Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes

被引：2
|
作者：
Chatterjee, Saurav [1 ,2 ]
Chatterjee, Sanjay [3 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Providence VAMC, Providence, RI USA
[3] Apollo Gleneagles Hosp, Kolkata, W Bengal, India
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 158卷 / 08期
关键词：
METAANALYSIS;
D O I：
10.7326/0003-4819-158-8-201304160-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 Diabetes
    Hinnen, Deborah
    DIABETES EDUCATOR, 2015, 41 : 19S - 31S
  • [22] The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety
    Green, Jennifer B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 54 - 61
  • [23] Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
    Richter, Bernd
    Bandeira-Echtler, Elizabeth
    Bergerhoff, Karla
    Lerch, Christian
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) : 753 - 768
  • [24] Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
    Yabe, Daisuke
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (05) : 475 - 477
  • [25] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    不详
    JOURNAL OF DIABETES, 2009, 1 (01) : 6 - 7
  • [26] Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy - focus on alogliptin
    Capuano, Annalisa
    Sportiello, Liberata
    Maiorino, Maria Ida
    Rossi, Francesco
    Giugliano, Dario
    Esposito, Katherine
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 989 - 1001
  • [27] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    Reaven, Peter
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 154 - 163
  • [28] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Lerch, C. L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [29] Dipeptidyl peptidase-4 inhibitors increase risk of IBD
    Reactions Weekly, 2018, 1696 (1) : 5 - 5
  • [30] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
    Lizan, L.
    Aceituno, S.
    Franch, J.
    Perez, A.
    Granell, M.
    Fuster, E.
    VALUE IN HEALTH, 2014, 17 (07) : A348 - A348
12345